Previous studies reported that genetic deletion and pharmacological inhibition of c-Abl alleviate the degeneration of motor neurons derived from patients with familial ALS harboring mutations in SOD1, C9orf72, TARDBP [17]. This evidence concerns the gene ABL1 and amyotrophic lateral sclerosis.